NLRP3-IN-73 (W16) is an orally bioavailable inhibitor that disrupts the assembly of the NLRP3 inflammasome, exhibiting an IC50 value of 0.18 µM for the NLRP3/IL-1beta pathway.
Target:
NOD-like Receptor (NLR)
* VAT and and shipping costs not included. Errors and price changes excepted